US2.8

Pharmaceutical giant Eli Lilly and Company (NYSE:LLY) is pushing further into the psychedelic drug market with a US$2.8 billion buyout of clinical-stage developer AtaiBeckley (NASDAQ:ATAI). The crown jewel of the…

Initially, back in early December 2025, I thought that Netflix’s inking of the acquisition of Warner Bros is done and dusted. Then subsequently, Paramount Skydance suddenly jumped in to offer…